MedTrace Logo

Salient Aquamantys Spine Trial

NCT01331499 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-06-07

No results posted yet for this study

Summary

The purpose of this study is to compare standard of care hemostasis techniques with and without the use of Aquamantys in reducing peri-operative blood loss.

Conditions

  • Blood Loss

Interventions

DEVICE

Bipolar Sealer (Aquamantys)

Standard of care blood sparing techniques along with the use of bipolar sealer

PROCEDURE

Standard of Care

Standard of care blood sparing techniques without the useof bipolar sealer

Sponsors & Collaborators

  • Salient Surgical Technologies

    lead INDUSTRY

Principal Investigators

  • Jeffrey Fischgrund, M.D. · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-12-31
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01331499 on ClinicalTrials.gov